Radiofrequency Catheter Ablation (RFCA) as second-line ... - NHS

43. Weerasooriya R, Jais P, Le Heuzey JY, Scavee C, Choi KJ, Macle L, et al. Cost analysisof catheter ablation for paroxysmal atrial fibrillation. Pace-Pacing and ClinicalElectrophysiology. 2003;26(1):292-4.44. Reynolds MR, Brown PP, Kugelmass AD, Cohen DJ, Simon AW, Culler SD. Frequencyand cost of complications of catheter ablation for atrial fibrillation in medicare patients.Circulation. 2008;117(21):214.45. Andrikopoulos G, Tzeis S, Maniadakis N, Mavrakis HE, Vardas PE. Cost-effectivenessof atrial fibrillation catheter ablation. Europace. 2009;11(2):147-51.46. Knight H. Personal Communication. Derbyshire County PCT. 2009.47 Stafford P. Personal Communication. Glenfield Hospital. UHL NHS Trust. May 2010.48 NCHOD. GP registered data. 2008.49. Cappato R, Calkins H, Chen SA, Davies W, Kalman J, Kim Y, et al. A worldwide surveyon the methods, efficacy and safety of catheter ablation for human atrial fibrillation.European Heart Journal. 2004;25:273-.50. al CHe. HRS/EHRA/ECAS expert consensus statement on catheter and surgicalablation of atrial fibrillation: recommendations for personnel, policy, procedures andfollow-up. A report of the Heart Rhythm Society (HRS) taskforce in catheter and surgicalablation of atrial fibrillation. Heart Rhythm2007. p. 816-61.51. Flaker GC, Fletcher KA, Rothbart RM, Halperin JL, Hart RG. CLINICAL ANDECHOCARDIOGRAPHIC FEATURES OF INTERMITTENT ATRIAL-FIBRILLATIONTHAT PREDICT RECURRENT ATRIAL-FIBRILLATION. American Journal ofCardiology. 1995;76(5):355-8.52. Phillips SJ, Whisnant JP, Ofallon WM, Frye RL. PREVALENCE OFCARDIOVASCULAR-DISEASE AND DIABETES-MELLITUS IN RESIDENTS OFROCHESTER, MINNESOTA. Mayo Clinic Proceedings. 1990;65(3):344-59.53. Kannel WB, Abbott RD, Savage DD, McNamara PM. CORONARY HEART-DISEASEAND ATRIAL-FIBRILLATION - THE FRAMINGHAM-STUDY. American Heart Journal.1983;106(2):389-96.54. Wilber DJ, Pappone C, Neuzil P et al. Comparison of antiarrhythmic drug therapy andRFCA inpatients with paroxysmal AF: a randomized controlled trial. JAMA; 303(4):333-34055. Packer DL, Lee KL, Mark DB, Monahan KH, Hoffmann KL, Hafley GE, Poole JE,Bahnson TD, Bradley DJ, Robb R, Rettmann M, Holmes III DR, Stevenson W, HummelJD, Bailin SJ, Day JD, Bhandari AK, Marchlinski F, Kay N, Calkins H, Wilber DJ.Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of theCABANA Pilot Study ACC Atlanta March 15, 201056. R J Hunter, T J Berriman, I Diab, V Baker, M Finlay, L Richmond, E Duncan, R Kamdar,G Thomas, D Abrams, M Dhinoja, S Sporton, M J Earley, R J Schilling. Long-termefficacy of catheter ablation for atrial fibrillation: impact of additional targeting offractionated electrograms. Heart Online First, published on May 18, 2010 as10.1136/hrt.2009.188128.57. Dagres N, Varounis C, Flevari P, Piorkowski C, Bode K, Rallidis LS, Tsougos E,Leftheriotis D, Sommer P, Hindricks G, Kremastinos DT. Mortality after catheter ablationDr Lauren Ahyow. RFCA for the treatment of atrial fibrillation. August 2010. 18